Press Releases

Jul 18, 2024
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
Jul 11, 2024
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
Jul 10, 2024
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
Jul 09, 2024
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
Jun 06, 2024
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
Jun 04, 2024
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
May 23, 2024
Twist Bioscience to Present at Upcoming Investor Conferences
May 13, 2024
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
May 08, 2024
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 02, 2024
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results